Journal of Targeted Oncology Research

Now Accepting Manuscripts Annual (One issue per year) Open Access Single-Blind Peer Review
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time

Immuno-Oncology

Immuno-oncology explores the use of the immune system to prevent, control, and treat cancer. Research in this field includes immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, and cellular immunotherapies. Advances in immuno-oncology continue to improve therapeutic options and contribute to the development of innovative cancer treatment approaches.